HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang H Paik Selected Research

amatuximab

1/2018Tumor-Shed Antigen Affects Antibody Tumor Targeting: Comparison of Two 89Zr-Labeled Antibodies Directed against Shed or Nonshed Antigens.
11/2015Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies.
11/2011Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang H Paik Research Topics

Disease

32Neoplasms (Cancer)
05/2020 - 02/2002
2Hodgkin Disease (Hodgkin's Disease)
05/2020 - 10/2015
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2020 - 10/2015
2Mesothelioma
01/2018 - 07/2005
2Neoplasm Metastasis (Metastasis)
09/2017 - 07/2008
2Myocardial Infarction
12/2016 - 02/2016
2Infarction (Infarctions)
12/2016 - 02/2016
2Hepatocellular Carcinoma (Hepatoma)
06/2015 - 01/2015
2Ovarian Neoplasms (Ovarian Cancer)
03/2010 - 07/2005
2Lymphoma (Lymphomas)
06/2009 - 08/2006
1Fibrosis (Cirrhosis)
02/2016
1HIV Infections (HIV Infection)
07/2009
1Carcinoma (Carcinomatosis)
08/2008
1Hematologic Neoplasms (Hematological Malignancy)
08/2008
1Prostatic Neoplasms (Prostate Cancer)
07/2008
1Pain (Aches)
07/2008
1Carcinogenesis
11/2007
1Leukemia
08/2006

Drug/Important Bio-Agent (IBA)

15Monoclonal AntibodiesIBA
11/2015 - 02/2002
9AntibodiesIBA
01/2018 - 08/2006
6AntigensIBA
05/2020 - 07/2008
5MesothelinIBA
01/2018 - 07/2005
4PeptidomimeticsIBA
03/2013 - 05/2007
3Lewis Y antigenIBA
01/2018 - 02/2008
3amatuximabIBA
01/2018 - 11/2011
3LigandsIBA
09/2017 - 03/2007
3Peptides (Polypeptides)IBA
12/2016 - 03/2007
3Therapeutic UsesIBA
01/2015 - 05/2004
3Radioisotopes (Radionuclides)IBA
11/2011 - 11/2007
2CollagenIBA
12/2016 - 02/2016
2IntegrinsIBA
10/2016 - 03/2013
2GlypicansIBA
06/2015 - 01/2015
2Photosensitizing Agents (Photosensitizers)IBA
01/2015 - 05/2014
2Immunoglobulin FragmentsIBA
01/2015 - 10/2013
2Cetuximab (Erbitux)FDA Link
05/2014 - 11/2007
2Paclitaxel (Taxol)FDA LinkGeneric
05/2012 - 08/2006
2Trastuzumab (Herceptin)FDA Link
03/2010 - 11/2007
2Immunoglobulin Fab FragmentsIBA
03/2010 - 02/2002
2Carcinoembryonic AntigenIBA
08/2008 - 07/2008
2DOTA-biotin (90Y-DOTA-biotin)IBA
07/2005 - 10/2002
1Carmustine (FIVB)FDA Link
05/2020
1Melphalan (Alkeran)FDA LinkGeneric
05/2020
1Cytarabine (Cytosar-U)FDA LinkGeneric
05/2020
1Etoposide (VP 16)FDA LinkGeneric
05/2020
1Daclizumab (Zenapax)FDA Link
05/2020
1Messenger RNA (mRNA)IBA
09/2017
1Chemokine ReceptorsIBA
09/2017
1ChemokinesIBA
09/2017
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2016
1N-end cysteine peptide tumor-homing peptideIBA
10/2016
1Coloring Agents (Dyes)IBA
10/2016
1DisulfidesIBA
10/2016
1cyclic arginine-glycine-aspartic acid peptideIBA
10/2016
1Neuropilin-1IBA
10/2016
1GadoliniumIBA
02/2016
1gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
02/2016
1Drug CarriersIBA
06/2015
1phthalocyanineIBA
01/2015
1130-nm albumin-bound paclitaxelIBA
01/2015
1Albumin-Bound PaclitaxelFDA Link
01/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2014
1Cell Surface ReceptorsIBA
11/2014
1Panitumumab (Vectibix)FDA Link
05/2014
1Immunoglobulin G (IgG)IBA
04/2014
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2013
1Fluorescent Dyes (Fluorescent Probes)IBA
10/2013
1Biomarkers (Surrogate Marker)IBA
05/2012
1Bevacizumab (Avastin)FDA Link
05/2012
1Chelating AgentsIBA
11/2011
1Integrin alphaVbeta3IBA
01/2010
1Biological ProductsIBA
01/2010
1EDDA (NiEDDA)IBA
01/2010
1Indium-111IBA
07/2009
1Yttrium-90IBA
06/2009
1Fas Ligand Protein (Fas Ligand)IBA
08/2008
1VaccinesIBA
08/2008
1Neoplasm Antigens (Tumor Antigens)IBA
07/2008
1Mucin-1 (CA 15-3 Antigen)IBA
07/2008
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2008
1RadiopharmaceuticalsIBA
07/2008
1Combined Antibody TherapeuticsIBA
11/2007
1Epidermal Growth Factor (EGF)IBA
11/2007
1CY5.5 cyanine dyeIBA
11/2007
1AvidinIBA
03/2007
1Peptide Hydrolases (Proteases)FDA Link
03/2007
1RhodaminesIBA
03/2007
1LectinsIBA
03/2007
1Interleukin-2 Receptor alpha SubunitIBA
08/2006
1Immunotoxins (Immunotoxin)IBA
08/2006
1Proteins (Proteins, Gene)FDA Link
07/2005
1Single-Chain AntibodiesIBA
07/2005
1Glycoproteins (Glycoprotein)IBA
07/2005
1StreptavidinIBA
07/2005
1BismuthIBA
05/2004

Therapy/Procedure

13Therapeutics
05/2020 - 10/2002
4Radioimmunotherapy
08/2012 - 07/2005
1Drug Therapy (Chemotherapy)
05/2020
1Intravenous Injections
10/2016
1Subcutaneous Injections
06/2009
1Immunotherapy
07/2008